ELAB — PMGC Holdings Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1840563 ·
Last close
$1.46
Market Cap
$6.63M
52W High
$14.00
52W Low
$1.34
ADV30
2,056,200
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 681,994 | 230,474 | -3,320,057 | -4,967,259 | 26,033,318 | 14,354,374 | 13,426,865 |
| Dec 2025 | 304,136 | 107,284 | -2,410,864 | -2,982,683 | 12,868,473 | 5,402,333 | 5,031,111 |
| Sep 2025 | 285,948 | 78,030 | -2,194,727 | -2,594,320 | 14,938,018 | 7,700,562 | 6,447,363 |
| Jun 2025 | 0 | — | -1,014,401 | -562,355 | 9,375,476 | 5,682,628 | 326,301 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,566,060
Investing CF
$-5,033,444
Financing CF
$21,586,459
CapEx
$-1,105,342
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-414.99
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-25,984,699
Inventory
$253,558
Receivables
$542,715
ST Investments
$733,405
EBIT TTM
$-10,434,391
Pretax Income TTM
$-11,155,717
Interest Exp TTM
$721,326
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,272,078
EBITDA
$-9,028,514
Free Cash Flow
$-2,403,837
Enterprise Value
$-618,966
Total Cash
$15,210,586
Total Debt
$7,957,106
Shares Out
4,543,751
Trailing EPS
$-150.06
Book Value
$6.51
ROE
-107.9%
ROA
-33.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 590,084 | -6,821,330 | -7,747,813 | 12,868,473 | 5,031,111 | — | -5,933,881 |
| Dec 2024 | 0 | -3,657,720 | -6,245,737 | 8,993,165 | 2,333,601 | — | -5,486,980 |
| Dec 2023 | 0 | -1,134,828 | -4,301,517 | 5,189,918 | 1,362,842 | — | -4,556,811 |
| Dec 2022 | 766,277 | -1,788,292 | -1,800,268 | 1,892,183 | 760,873 | — | -1,585,876 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SNGX | SOLIGENIX, INC. | $6.67M | $0.45 | — |
| ACXP | Acurx Pharmaceuticals, Inc. | $6.75M | $1.57 | — |
| SILO | Silo Pharma, Inc. | $6.86M | $6.33 | — |
| CANF | Can-Fite BioPharma Ltd. | $6.41M | $2.99 | — |
| CNSP | CNS Pharmaceuticals, Inc. | $6.93M | $4.74 | — |
News headlines (Yahoo Finance, 1h cache)
PMGC Holdings Highlights Advanced Precision Manufacturing Capabilities Supporting Space Exploration Supply Chains
2026-06-10 11:31 · Yahoo
NorthStrive Defense Tech Executes Binding Agreement to Acquire Exclusive License to Patented Multi-Domain Drone Payload Technology for Defense, Aerospace and Maritime Applications
2026-06-08 11:31 · Yahoo
PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor Markets
2026-06-01 11:31 · Yahoo
GB Capital Ltd. Co-Advises on the Acquisition of A&B Aerospace Inc.
2026-05-18 13:00 · Yahoo
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q1 2026 Results and Files Form 10-Q; Total Assets Reach Over $26.0 Million, Up 102% from Year-End 2025 and 193% Year-over-Year
2026-05-15 11:02 · Yahoo
PMGC Grabs Precision Parts Maker Serving Boeing, Honeywell
2026-05-13 12:42 · Yahoo
PMGC Holdings (NASDAQ: ELAB) Acquires A&B Aerospace, Inc.
2026-05-13 08:03 · Yahoo
UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions related to GLP-1 Use, Sarcopenia, Muscle Disuse Atr
2026-04-28 20:01 · Yahoo
NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans
2026-04-28 11:30 · Yahoo
NorthStrive Defense Tech Acquires Patented GPS-Denied Autonomous Drone Navigation Technology Option, Built for Defense and Counter-Unmanned Aircraft Systems
2026-04-23 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.